Additionally, bile acid metabolism by intestinal flora activates the nuclear bile acid receptor farnesoid X receptor (FXR) signaling, thereby affecting the progression of NAFLD [11]. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.